Corrigendum to "Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients” [Int. J. Cardiol. 124 (2008) 166-171] (Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients (2008) 124(2) (166-171), (S0167527307003518), (10.1016/j.ijcard.2006.12.034))

RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice

P430RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice

In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor

A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease

Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice

Epigenetic histone acetylation modifiers in vascular remodelling: New targets for therapy in cardiovascular disease

Critical role of tissue kallikrein in vessel formation and maturation: Implications for therapeutic revascularization

Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis

Proteomic and meatbolomic analysis of smooth muscle cells derived from the arterial media and adventitial progenitors of apolipoprotein E-deficient mice

Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients

Increased infiltration of Chlamydophila pneumoniae in the vessel wall of human veins after perfusion

Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction

Vascular Growth in Ischemic Limbs: A Review of Mechanisms and Possible Therapeutic Stimulation

Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity

Insights into mechanisms behind arteriogenesis: What does the future hold?

Natural killer cells and CD4+ T-cells modulate collateral artery development

The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions

Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists

Interleukin 10: A new risk marker for the development of restenosis after percutaneous coronary intervention